Key facts
- Viz.ai’s last known valuation is $1.2B (Apr 2022).
- It has raised $289.2M across 2 recorded rounds; the latest was Seed Round ($4.8M) in May 2017.
- Notable investors include Insight Partners (New York), GV, Tiger Global Management, Kleiner Perkins, Pear (California) — 27 tracked in total.
- Viz.ai has filed 2 Form Ds with the SEC since 2016, most recently May 2017 ($4.8M sold to 5 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Viz.ai
Funding rounds
2 roundsAbout Viz.ai
Developer of an intelligent care coordination platform designed to fundamentally improve how healthcare is delivered in the world. The company's platform leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist for treatment, enabling healthcare providers to reduce the time of treatment and improve access to care.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 327
- Website
- viz.ai/
- Ownership
- Privately Held (backing)
Viz.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Viz.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Viz.ai in its N-PORT filings yet. We sweep new filings monthly.